Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GenePeeks names new chair

This article was originally published in Scrip

Executive Summary

Lifeprint Group, the parent company for GenePeeks – a genetic information company focused on next-generation disease risk analysis – has named Mara Aspinall executive chair of its board of directors. Ms Aspinall is the former president and CEO of Ventana Medical Systems. Vertana is a member of the Roche Group and a leader in the development, manufacture and commercialization of tissue-based cancer diagnostics that enable the delivery of personalized healthcare to patients. Previously, Ms Aspinall spent 12 years with Genzyme, where she held leadership roles that included president of Genzyme Genetics and president of Genzyme Pharmaceuticals.

Advertisement
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC028349

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel